UBC Medical Indonesia Tbk. vs Bakrie Sumatera Plantations Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Bakrie Sumatera Plantations Tbk. trades at Rp206 (market cap 495.03B, 8.12M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Bakrie Sumatera Plantations Tbk. is more actively traded (8.12M versus 635.5K). Which is the better fit depends on your goals.
| LABS | UNSP | |
|---|---|---|
Market Cap | 691.25B | 495.03B |
Volume | 635.5K | 8.12M |
Lot | 6.36K | 81.22K |
Turnover | 110.15M | — |
Average Price | 173.33 | — |
Value | 110.15M | — |
Indicative Equilibrium Price | 174 | — |
Indicative Equilibrium Volume | 50 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Bakrie Sumatra Plantation Tbk (the Company) was established in the Republic of Indonesia in 1911 as a joint venture between the United States and Netherland Companies under the name of NV Hollandsch Amerikaanse Plantage Maatschappij. The Company status is Domestic Investment and has 8822 employees.
Read more on UNSP →